PGD – Live Attenuated Influenza Vaccine Nasal Spray Suspension (2-18yrs) National Imm. Prog.

Rotherham Doncaster and South Humber NHS Foundation Trust Patient Group Direction (PGD) for the Administration of Live Attenuated Influenza Vaccine Nasal Spray Suspension or supply only in well-defined local circumstances, to children and adolescents from 2-18 years in Accordance with the National Flu Immunisation Programme for Active Immunisation Against Influenza

This Patient Group Direction is for the administration of Live Attenuated Influenza Vaccine (LAIV) Nasal Spray Suspension (Fluenz Tetra) by registered healthcare practitioners identified, subject to any limitations to authorisation as detailed.

Public Health England has developed this PGD to facilitate the delivery of publicly-funded immunisation in line with national recommendations.

To download the PGD please follow the link:  LAIV PGD v8

To download the Equality Impact Assessment associated with this PGD please follow the link:  Equality Impact Assessment